James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 25,000 shares at $24.18 ($605K) on 2022-12-12, disclosed to the SEC on 2022-12-14.
Open-market sale of $604k TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |